SCM
TECH icon

Silvant Capital Management’s Bio-Techne TECH Stock Holding History

Silvant Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,204
Closed -$436K – 343
2020
Q1 		$436K Hold
9,204
– – 0.1% 109
2019
Q4 		$505K Hold
9,204
– – 0.09% 111
2019
Q3 		$450K Hold
9,204
– – 0.09% 112
2019
Q2 		$480K Hold
9,204
– – 0.09% 115
2019
Q1 		$457K Hold
9,204
– – 0.08% 122
2018
Q4 		$333K Hold
9,204
– – 0.07% 139
2018
Q3 		$470K Hold
9,204
– – 0.06% 129
2018
Q2 		$340K Hold
9,204
– – 0.04% 150
2018
Q1 		$348K Buy
+9,204
New +$325K 0.04% 149

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Silvant Capital Management's TECH Position: Q2 2020 in Review

Silvant Capital Management sold out of Bio-Techne (TECH) in Q2 2020, closing a stake of 9,204 shares — an estimated $436K sold.

Silvant Capital Management first reported a position in TECH in Q1 2018 and held it in 9 quarters. The position peaked at $505K in Q4 2019. 393 funds tracked by Wall St. Rank hold TECH as of Q2 2020.

  • Silvant Capital Management reported no remaining Bio-Techne position as of Q2 2020 after selling out during the quarter.
  • Silvant Capital Management sold 9,204 Bio-Techne shares in Q2 2020, an estimated $436K.
  • Silvant Capital Management first reported a position in Bio-Techne in Q1 2018 and held it in 9 quarters.
  • Silvant Capital Management's Bio-Techne position peaked at $505K in Q4 2019.
  • 393 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2020.

Based on Silvant Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.